Ligand · DT2
DT2 · 4-{[5-(cyclohexylamino)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide
DT2, 4-{[5-(cyclohexylamino)[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino}benzenesulfonamide (C17 H21 N7 O2 S, 387.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within…
- Component
- DT2
- Formula
- C17 H21 N7 O2 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
DT2 in 2 structures; the first of them:
- 2C6K · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT2 A1299 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 11 more
- 2C6K · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · DT2 A1299 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 11 more
Residues it binds most
ALA 2, GLN 2, GLU 2, GLY 2, LEU 2, LYS 2, PHE 2, VAL 2, ASP 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.